McWin, a private investment firm, and Rage Capital, a venture capital firm, led a $175m Series C funding round in The EVERY Company, a precision fermentation platform accelerating a global transition to animal-free protein. Additional investors include Temasek, Wheatsheaf Group, TO Ventures and Prosus Ventures. “It’s rare for a company to credibly claim revolutionizing a century-old industry. Arturo and the team at EVERY™ are doing just that. By leveraging precision fermentation technologies, EVERY™ is bringing ingredient synthesis from science fiction to supermarket aisles, starting with egg proteins and enzymes. We look forward to supporting the company in the commercialization of such exciting innovation in the next years," Gabriel Ruimy, Rage Capital Managing Partner.